[go: up one dir, main page]

GB0818627D0 - Protein - Google Patents

Protein

Info

Publication number
GB0818627D0
GB0818627D0 GBGB0818627.2A GB0818627A GB0818627D0 GB 0818627 D0 GB0818627 D0 GB 0818627D0 GB 0818627 A GB0818627 A GB 0818627A GB 0818627 D0 GB0818627 D0 GB 0818627D0
Authority
GB
United Kingdom
Prior art keywords
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB0818627.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Priority to GBGB0818627.2A priority Critical patent/GB0818627D0/en
Publication of GB0818627D0 publication Critical patent/GB0818627D0/en
Priority to PCT/GB2009/002291 priority patent/WO2010043842A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB0818627.2A 2008-10-13 2008-10-13 Protein Pending GB0818627D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0818627.2A GB0818627D0 (en) 2008-10-13 2008-10-13 Protein
PCT/GB2009/002291 WO2010043842A1 (en) 2008-10-13 2009-09-29 Staphylococcus protein essential for growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0818627.2A GB0818627D0 (en) 2008-10-13 2008-10-13 Protein

Publications (1)

Publication Number Publication Date
GB0818627D0 true GB0818627D0 (en) 2008-11-19

Family

ID=40083849

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0818627.2A Pending GB0818627D0 (en) 2008-10-13 2008-10-13 Protein

Country Status (2)

Country Link
GB (1) GB0818627D0 (en)
WO (1) WO2010043842A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4227685A3 (en) * 2013-12-03 2024-02-28 Evaxion Biotech A/S Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
US20050026189A1 (en) * 2003-05-29 2005-02-03 Liangsu Wang Microbial operons

Also Published As

Publication number Publication date
WO2010043842A1 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
HK1218558A1 (en) Mirac proteins mirac
LT3118220T (en) Protein
ZA201005245B (en) Protein expression systems
GB2462761B (en) Protein formulation
GB0920981D0 (en) Peptides
GB2466379B (en) Protein stabilizer
IL194940A0 (en) Protein assay
GB0816976D0 (en) Protein
EP2314681A4 (en) Modified biotin-binding protein
GB0816702D0 (en) Complement proteins
GB0817507D0 (en) Protein cages
ZA201109283B (en) Protein
GB0719231D0 (en) Protein
GB0920987D0 (en) Peptides
GB0813253D0 (en) Protein expression system
GB2462726B (en) Protein expression
GB0818627D0 (en) Protein
GB0720563D0 (en) Protein
GB0817978D0 (en) Peptides
GB0817077D0 (en) Proteins
GB0810567D0 (en) Protein expression
GB0811893D0 (en) Protein expression
GB0713302D0 (en) Protein
GB0719236D0 (en) Protein
GB0909384D0 (en) Protein